Eisai and Biogen have received FDA approval for LEQEMBI IQLIK (lecanemab-irmb), a new autoinjector for maintaining treatment in early Alzheimer’s […]

Otello Stampacchia, a seasoned biotech investor, has seen the industry face many tough times over the past 20 years. He

A new pharmaceutical startup called Braveheart Bio has just acquired the rights to a promising heart medication originally developed in

A debate between Stealth BioTherapeutics and the FDA over a drug for Barth syndrome—a rare, often fatal childhood disease—could set

The European Medicines Agency (EMA) has issued a serious warning about a sharp rise in illegal weight loss drugs being

A recent government notice confirmed the dates for an important meeting where experts will discuss and possibly vote on recommendations

Here’s a quick rundown of recent news from major pharmaceutical companies that you might have missed. Amylyx Pharmaceuticals announced that

Starting in January 2026, the NHS in England will provide the chickenpox vaccine to children as part of their routine